Comment by jonlucc

Worse, I fear that cancer patients and their loved ones will get overly enthusiastic about this. Then, when they donate tons of money and it fails, they are out money, time, and a drug. This is the reason pharmaceutical companies are cautious about contacting patient advocacy groups.